I still remember the first time I learned that helium wasn’t just for party balloons. At a university lab open day, a researcher showed me a dilution refrigerator used for quantum experiments and explained that a steady supply of helium-3 and helium-4 is literally the lifeblood of the machine. That stuck with me. Since then, I’ve spent time following how helium is sourced, stored, and priced — and how fragile that chain can be. In this piece I’ll walk you through why this "invisible" market is worth roughly $20 billion, how shortages threaten both cutting-edge quantum computing research and everyday medical imaging like MRIs, and what practical steps governments, hospitals, and tech companies can take to reduce risk. I’ll keep it accessible and actionable, because the consequences affect not just researchers but patients and industries around the world.
Introduction: Why Helium Matters More Than You Think
When people hear "helium," most immediately think of balloons or party decorations. But helium's physical and chemical properties — the lowest boiling point of any element, inertness, and light atomic mass — make it uniquely valuable in applications where cooling, non-reactivity, or leakage minimization are essential. Helium’s special role appears in two areas that seem worlds apart yet are both highly vulnerable to supply interruptions: quantum computing and magnetic resonance imaging (MRI). Quantum machines require ultra-low temperatures to keep qubits coherent, often achieved through superfluid helium or helium-cooled dilution refrigerators. Meanwhile, MRI scanners rely on superconducting magnets that are routinely cooled with liquid helium to maintain superconductivity. Without reliable helium, both research infrastructure and clinical diagnostic services can face downtime, degraded performance, and skyrocketing costs.
Beyond these technical uses, helium’s market has characteristics that make it "invisible" and volatile. It’s a byproduct of natural gas extraction in only a handful of geographic locations, and historically it’s been captured opportunistically rather than being the primary resource targeted by producers. That makes the supply both geographically concentrated and price-sensitive to decisions in the energy sector, export policies, and single-point production disruptions. Add to that complexities like the distinction between helium-3 and helium-4, the different handling and purification steps required, and the long-term storage and transport logistics — and you have a market that can swing from comfortable surplus to acute shortage faster than many stakeholders realize.
In this article I’ll use plain language, but I’ll also include practical details: how the market operates, recent trends that shaped supply risk, why that risk matters specifically for quantum computing and MRI services, what mitigation strategies exist (from recycling and alternative cooling tech to policy and supply diversification), and what individuals or organizations can do right now. I’ll also point you toward a couple of authoritative institutions where you can follow policy guidance and scientific updates. If you manage research facilities, run a hospital imaging center, or work in supply-chain planning, some of the operational recommendations here should be directly useful. Even if you don’t, you’ll come away with a clearer sense of how a niche commodity can have outsized social and technological impact.
Quick orientation: in the sections that follow, I’ll first break down the market itself and why its structure creates systemic risk. Then I’ll dive into the technical dependencies of quantum systems and MRI infrastructure. Finally, I’ll discuss current mitigation strategies, promising innovations, and practical steps for stakeholders — including a call to action with reliable resources to follow. Let’s begin with the market fundamentals.
The $20 Billion Helium Market: Supply, Demand, and Why It's "Invisible"
To understand why helium’s market is fragile, we need to look at how helium is produced, where value is captured, and how end-users interact with that market. First, helium is not mined directly in most cases; it is separated from natural gas streams where it occurs in trace concentrations. Only a small number of gas fields worldwide have economically recoverable concentrations of helium. Historically, the global supply has come from countries like the United States, Qatar, Algeria, Russia, and a few others. Production is intimately tied to decisions in the natural gas industry: if a gas field is not profitable or if operators decide not to invest in helium extraction equipment, the helium simply goes uncollected and is vented or lost.
This byproduct status has two crucial consequences. One, helium supply depends on the broader energy sector rather than a dedicated commodity market that can scale production in response to demand signals. Two, because production is geographically concentrated, local political decisions, export policies, or geopolitics can abruptly change global availability. For example, export restrictions or domestic reservation policies (where a producing country prioritizes domestic supply for strategic reasons) can remove large volumes from the global market with little notice. The result: sudden price spikes and difficulty for buyers to secure long-term contracts.
The figure often quoted in policy and industry reports — roughly a $20 billion global market value for helium and its services — captures not just the raw gas but also the downstream value of cryogenic services, medical device uptime, research infrastructure, and industrial processes. Helium is used in controlled atmospheres for semiconductor manufacturing, welding, leak detection, fiber optics production, scientific research, and more. Each of these industries depends on predictable supply, and many of them require helium in particular purity grades, which adds complexity and cost. Purification and liquefaction facilities add capital and lead times to bringing new supply online, so even when new helium-bearing fields are discovered, it can take years to convert potential into usable supply.
The market’s structure also affects inventory and recycling incentives. In many medical centers and research labs, the cost of helium is a line item but historically considered modest relative to equipment costs. That has discouraged proactive investment in closed-loop recovery systems. As prices rose in past supply disruptions, some facilities found themselves unprepared and suffering unplanned downtime or prohibitively high refill costs. The economics are changing: recycling systems and on-site liquefaction, while capital intensive, are becoming more attractive where helium prices and supply risk are high. There’s also commercial growth in helium reclamation service providers who offer recovery solutions to labs and hospitals — a shift from a single-use mindset toward circular resource management.
From a policy perspective, the "invisibility" of helium has yielded underinvestment in strategic reserves and market oversight. Unlike oil, many countries do not track helium as a critical commodity with national reserves or coordinated stockpiles. That has begun to change in recent years as governments and industries recognize the strategic importance of reliable helium. Meanwhile, research institutions and medical providers are increasingly pushing for contracts that include priority or guaranteed deliveries, as well as investment in redundancy and recycling. Nonetheless, these changes require time, capital, and coordinated policy action — and the production side can still present single points of failure.
In short, the $20 billion figure masks a market that is small in dollar terms compared to global energy markets but disproportionately critical to high-value, time-sensitive applications. The market’s geography, byproduct nature, purity requirements, and long lead times for new capacity make it uniquely vulnerable to shocks. The next section explains why that vulnerability matters so much for quantum computing and MRI services — systems for which helium is not merely a convenience but an operational necessity.
How Helium Shortages Threaten Quantum Computing and MRI Services
The technical reasons helium is indispensable to both quantum computing and MRI are connected: both require maintaining devices at cryogenic temperatures where superconductivity or quantum coherence can exist. But the operational realities and consequences differ, which affects how shortages play out in practice.
Quantum computing: Many quantum systems — especially those based on superconducting circuits and certain other qubit platforms — operate at millikelvin temperatures. Achieving those temperatures involves multi-stage refrigeration, often culminating in dilution refrigerators that rely on helium-3/helium-4 mixtures to reach the necessary cryogenic baths. Helium-3, in particular, is scarce and expensive because it is a rare isotope produced largely through tritium decay or specialized separation processes. A steady supply of helium-4 is also essential for cooling systems and for topping up cryostats when there is boil-off. When helium supplies tighten, research groups and quantum hardware firms can’t scale experiments, maintain qubit uptime, or keep prototype systems online. Delays in research and development cascade into delayed product roadmaps, missed milestones, and increased costs for scaling quantum hardware.
MRI services: MRIs use large superconducting magnets that are kept at liquid helium temperatures to remain in a superconducting state. Historically, MRI systems required periodic helium fills due to system boil-off or maintenance; some modern scanners use zero-boil-off designs or cryocoolers that reduce helium loss but not all installed systems have that capability. For hospitals and imaging centers, helium supply interruptions can force reduced scanner availability, longer patient wait times, and expensive emergency purchases of helium. For critical diagnoses, delayed MRI scans can have real health consequences. For hospitals operating on tight budgets, spikes in helium price can quickly erode margins on imaging services. The healthcare sector’s expectations around uptime and regulatory compliance mean that supply shocks can produce cascading operational challenges, from rescheduling patients to extending equipment leases or purchasing recovery systems under duress.
Beyond downtime, there are other technical impacts. In quantum labs, interruptions that lead to warm-up cycles can damage delicate components or create long recalibration windows, costing weeks or months in lost research time. For MRI systems, emergency warm-ups and re-cooling can require specialized service teams and hours of machine downtime. In both sectors, the human cost includes technician overtime, re-prioritization of cases or experiments, and the administrative burden of sourcing emergency supplies at premium prices.
The broader industry impact is also worth noting. As quantum hardware firms push toward commercialization, manufacturing lines require stable cryogenic infrastructure and predictable helium logistics. If helium becomes a bottleneck at scale, companies may slow production, raise prices, or shift manufacturing closer to helium sources — all of which introduce new cost structures and potential geopolitical vulnerabilities. For healthcare providers, uneven helium availability might accelerate equipment turnover toward systems with integrated cryocooling and built-in redundancy. This transition can be capital-intensive and unevenly accessible, potentially widening disparities in diagnostic availability between well-resourced and under-resourced hospitals.
Finally, there's an ecosystem effect: as sectors compete for limited helium supplies during shortages, priority decisions become necessary. Will limited helium go to defense-related cryogenic systems, semiconductor fabs, or to hospitals needing MRIs? These allocation choices have ethical, economic, and policy dimensions. Some countries have begun to designate helium as a strategic resource, establishing priority rules for critical services. Others are investing in national reserves or incentivizing recovery technologies. But implementation is uneven and often reactive. For stakeholders in quantum research or medical imaging, the prudent approach is to assume supply volatility and plan accordingly through redundancy, recovery, contractual protections, and investments in helium-minimizing technologies.
Solutions and Practical Steps: Technology, Policy, and Procurement
Addressing helium risk requires coordinated action across technology, procurement practices, and policy. There is no single silver bullet, but a layered strategy can substantially reduce vulnerability. Below I outline practical steps and emerging solutions that organizations can adopt, along with policy recommendations that make systemic sense.
1. Invest in recycling and recovery systems. For research labs and imaging centers, closed-loop helium recovery systems are now commercially available that can capture boil-off gas, purify it, and return it to the cryostat or into a stored liquid pool. The capital expense can be significant, but when amortized over several years — particularly in environments with high helium prices or frequent refills — the payback can be attractive. Recovery systems are especially valuable for large facilities with multiple cryostats or several MRI scanners clustered in one location. For smaller labs, shared recovery services or regional reclamation providers can achieve economies of scale.
2. Adopt technology that reduces helium demand. Zero-boil-off MRI designs and cryocooler-enabled superconducting systems reduce or eliminate routine helium top-offs. Similarly, cryogen-free dilution refrigeration technologies and high-efficiency cryocoolers for quantum systems are maturing. These technologies sometimes involve trade-offs in terms of upfront cost, maintenance complexity, or ultimate performance envelope, but for many use cases they dramatically reduce dependency on delivered liquid helium. When purchasing new equipment, procurement teams should require assessments of lifecycle helium usage and consider long-term operational costs rather than just initial price.
3. Strengthen procurement and contract practices. Facilities should negotiate long-term supply contracts with firm delivery commitments, price collars, and priority clauses where possible. Pooling purchasing across hospital networks or university consortia can create bargaining power and enable bulk contracting. Additionally, contracts with reclamation or on-site liquefaction providers can secure local resilience. Insurance-style arrangements — for example, keeping a minimal strategic reserve in secure storage — can provide breathing space during short-term disruptions.
4. Diversify supply and encourage new production investment. Governments can incentivize dedicated helium extraction at gas fields or support public-private partnerships for purification and liquefaction plants. Fiscal policies or guarantees that reduce the capital risk of building helium infrastructure can have outsized effects because a single new plant can supply large regions. Where geopolitical concentration is a concern, import diversification and regional reserves help smooth shocks.
5. Create strategic reserves and clearer allocation policies. Several countries have begun the conversation about treating helium as a strategic resource. Establishing reserves targeted for critical public goods (e.g., medical and national research priorities) and transparent allocation rules during crises can reduce ad hoc and inequitable distributions. Policy frameworks should also encourage industry-standard transparency in reporting helium stocks and flows so markets can respond more rationally to supply changes.
6. Support innovation in alternate technologies and isotopic substitution. Helium-3 is particularly scarce and critical for certain low-temperature research. Investments in alternative cooling techniques, research into less helium-intensive qubit platforms, and improved isotopic separation technologies can reduce long-term pressure on scarce isotopes. While some quantum platforms inherently rely less on helium cooling, transitioning an entire research ecosystem takes time and coordinated funding.
7. Operational preparedness and contingency planning. For hospitals and labs, build explicit contingency plans: what to do if deliveries are delayed, which services are critical and must be prioritized, and how to redeploy equipment or reschedule non-urgent work. Regular drills, inventory audits, and relationships with multiple suppliers reduce single-point failures. Technical staff training on helium reclamation and emergency warm-up procedures also reduces recovery time following disruptions.
8. Foster collaborative research and public awareness. Academia, industry, and government should share best practices and co-invest in infrastructure where feasible. Public awareness campaigns that explain helium’s strategic role can build support for policy measures like targeted subsidies or reserve funds. Greater visibility in public policy discussions helps shift helium from an "invisible" niche commodity to recognized critical infrastructure.
Taken together, these measures reduce short-term pain and build long-term resilience. For managers making procurement decisions today, prioritize recovery and cryogen-free designs where feasible, negotiate supply security with clear service-level expectations, and coordinate with peers to pool purchasing or share recovery assets. For policymakers, the low-dollar but high-impact nature of helium argues for targeted interventions: strategic reserves, incentives for capital investment in purification capacity, and transparent allocation rules during crises.
Actionable Takeaways & Call to Action
If you read this far, you understand that helium is a small but critical market whose instability can have outsized effects on health systems and emerging technologies. Here are concise, actionable steps tailored to different readers:
- Hospital administrators: Audit your MRI fleet’s helium consumption and prioritize investments in recovery systems or cryocooler upgrades for scanners nearing end-of-life. Negotiate supply contracts with clauses for priority delivery in shortages.
- Research lab managers and quantum hardware teams: Budget for helium reclamation where continuous cryogenic operation is needed. Where possible, evaluate cryogen-free refrigeration options and factor helium scarcity risk into timelines and scaling plans.
- Procurement and supply-chain officers: Explore consortium purchasing and build redundancy into supplier lists. Consider investing in on-site short-term storage to smooth minor supply hiccups.
- Policy makers: Consider helium strategic reserves for critical services, incentives for new purification capacity, and transparency requirements for production and stock reporting.
If you want to stay informed about standards and research related to cryogenics and national-level guidance, check resources such as https://www.nist.gov for standards and measurement science, and for medical device guidance see https://www.fda.gov. These organizations provide authoritative perspectives that can help you align procurement and compliance practices.
If you manage equipment that depends on helium, start by requesting a helium-risk assessment from your facilities or procurement team. If you'd like to share your experience or ask for practical implementation tips, contact peers through professional networks or professional societies that focus on cryogenics or medical imaging.
Summary: What to Remember
Helium is small in headline market value but enormous in practical impact because of its role in cryogenics. The market’s byproduct nature, production concentration, and long lead times for new capacity create a fragile supply-demand balance. That fragility matters to quantum computing and MRI operations because both depend on stable cryogenic conditions that helium uniquely provides. The good news is that effective mitigation strategies exist: recovery and recycling, cryogen-free technologies, smarter procurement and long-term contracting, diversification of supply, and policy measures such as strategic reserves. The faster organizations that depend on helium adopt a layered approach — combining technology upgrades, operational readiness, and procurement resilience — the less likely they are to suffer severe disruption during the next market shock.
If you are responsible for equipment or planning in affected sectors, start with an inventory and risk assessment. Consider capital investments where savings and resilience justify the cost, and collaborate with peers to improve negotiating leverage. For policymakers, targeted, proportionate interventions can secure critical services without overcorrecting an otherwise efficient market. Ultimately, treating helium as what it is — a small-dollar but high-strategic-value commodity — will lead to smarter decisions that protect patients, advance research, and sustain emerging technologies.
Thanks for reading. If you found this helpful, please share it with colleagues in procurement, facilities, and R&D — and consider bookmarking authoritative resources like NIST and FDA to stay updated on standards and guidance.